Enovis [ENOV] vs Axogen [AXGN] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Enovis Corporation wins in 10 metrics, Axogen Inc. wins in 8 metrics, with 1 ties. Enovis Corporation appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Enovis Corporation | Axogen Inc. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -1.10 | -110.18 | Enovis Corporation |
| Price-to-Book Ratio | 0.91 | 13.15 | Enovis Corporation |
| Debt-to-Equity Ratio | 92.47 | 55.50 | Axogen Inc. |
| PEG Ratio | 0.04 | 0.04 | Tie |
| EV/EBITDA | 7.33 | -2,165.44 | Enovis Corporation |
| Profit Margin (TTM) | -52.69% | -6.97% | Axogen Inc. |
| Operating Margin (TTM) | 6.09% | -16.31% | Enovis Corporation |
| EBITDA Margin (TTM) | 6.09% | N/A | N/A |
| Return on Equity | -58.27% | -13.49% | Axogen Inc. |
| Return on Assets (TTM) | 1.09% | -2.31% | Enovis Corporation |
| Free Cash Flow (TTM) | $19.92M | $-4.78M | Enovis Corporation |
| 1-Year Return | -27.54% | 262.53% | Axogen Inc. |
| Price-to-Sales Ratio (TTM) | 0.61 | 8.27 | Enovis Corporation |
| Enterprise Value | $2.71B | $1.89B | Enovis Corporation |
| EV/Revenue Ratio | 1.20 | 8.40 | Enovis Corporation |
| Gross Profit Margin (TTM) | 60.69% | 74.13% | Axogen Inc. |
| Revenue per Share (TTM) | $39 | $5 | Enovis Corporation |
| Earnings per Share (Diluted) | $-20.72 | $-0.34 | Axogen Inc. |
| Beta (Stock Volatility) | 1.59 | 0.98 | Axogen Inc. |
| Short % of Float | 16.89% | 6.92% | Axogen Inc. |
Enovis Corporation vs Axogen Inc. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Enovis Corporation | -1.80% | -9.64% | -6.00% | -14.63% | -25.32% | -17.24% |
| Axogen Inc. | 2.97% | -4.80% | -7.44% | 28.74% | 42.51% | 27.29% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Enovis Corporation | -27.54% | -59.67% | -71.23% | -53.24% | -39.81% | -35.71% |
| Axogen Inc. | 262.53% | 346.61% | 108.01% | 590.21% | 1,114.77% | 9,770.00% |
Performance & Financial Health Analysis: Enovis Corporation vs Axogen Inc.
| Metric | ENOV | AXGN |
|---|---|---|
| Market Information | ||
| Market Cap | $1.31B | $1.94B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 793,145 | 1,245,238 |
| 90 Day Avg. Volume | 806,505 | 1,068,353 |
| Last Close | $21.55 | $40.63 |
| 52 Week Range | $20.82 - $36.82 | $9.22 - $45.83 |
| % from 52W High | -41.49% | -11.35% |
| All-Time High | $129.72 (Jun 09, 2014) | $56.85 (Jul 23, 2018) |
| % from All-Time High | -83.39% | -28.53% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.03% | 0.21% |
| Quarterly Earnings Growth | 0.03% | 0.21% |
| Financial Health | ||
| Profit Margin (TTM) | -0.53% | -0.07% |
| Operating Margin (TTM) | 0.06% | -0.16% |
| Return on Equity (TTM) | -0.58% | -0.13% |
| Debt to Equity (MRQ) | 92.47 | 55.50 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $26.05 | $2.73 |
| Cash per Share (MRQ) | $0.64 | $0.80 |
| Operating Cash Flow (TTM) | $217.29M | $812,000 |
| Levered Free Cash Flow (TTM) | $104.43M | $3.58M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | $0.00 | $0.00 |
Valuation & Enterprise Metrics Analysis: Enovis Corporation vs Axogen Inc.
| Metric | ENOV (Apr 23, 2026) | AXGN (Apr 24, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -1.10 | -110.18 |
| Forward P/E | 5.94 | 47.31 |
| PEG Ratio | 0.04 | 0.04 |
| Price to Sales (TTM) | 0.61 | 8.27 |
| Price to Book (MRQ) | 0.91 | 13.15 |
| Market Capitalization | ||
| Market Capitalization | $1.31B | $1.94B |
| Enterprise Value | $2.71B | $1.89B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.20 | 8.40 |
| Enterprise to EBITDA | 7.33 | -2,165.44 |
| Risk & Other Metrics | ||
| Beta | 1.59 | 0.98 |
| Book Value per Share (MRQ) | $26.05 | $2.73 |
Financial Statements Comparison: Enovis Corporation vs Axogen Inc.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | ENOV (2025) | AXGN (2025) |
|---|---|---|
| Revenue/Sales | 2.25B | 225.21M |
| Cost of Goods Sold | 902.79M | 57.86M |
| COGS % of Revenue | 40.2% | 25.7% |
| Gross Profit | 1.35B | 167.35M |
| Gross Margin | 59.8% | 74.3% |
| Research & Development | 120.33M | 32.89M |
| Operating Income (EBIT) | -18.87M | -7.85M |
| Operating Margin | -0.8% | -3.5% |
| EBITDA | 275.14M | 826,000 |
| EBITDA Margin | 12.2% | 0.4% |
| Pre-Tax Income | -1.16B | -15.70M |
| Pre-Tax Income % of Revenue | -51.6% | -7.0% |
| Income Tax | 22.29M | N/A |
| Income Tax % of Revenue | 1.0% | 0.0% |
| Net Income (Profit) | -1.18B | -15.70M |
| Profit Margin | -52.7% | -7.0% |
Balance Sheet & Liquidity Metrics
| Metric | ENOV (2025) | AXGN (2025) |
|---|---|---|
| Cash & Equivalents | 36.39M | 35.55M |
| Total Current Assets | 1.21B | 120.42M |
| Total Current Assets % of Revenue | 53.7% | 53.5% |
| Total Current Liabilities | 598.47M | 23.56M |
| Total Current Liabilities % of Revenue | 26.6% | 10.5% |
| Long-Term Debt | 1.32B | 65.26M |
| Long-Term Debt % of Revenue | 58.7% | 29.0% |
| Total Shareholders Equity | 1.49B | 128.85M |
| Retained Earnings | -1.47B | -306.96M |
| Retained Earnings % of Revenue | -65.3% | -136.3% |
| Property, Plant & Equipment | 72.26M | 29.38M |
Cash Flow Statement Comparison
| Metric | ENOV (2025) | AXGN (2025) |
|---|---|---|
| Operating Cash Flow | -835.70M | 10.26M |
| Operating Cash Flow % of Revenue | -37.2% | 4.6% |
| Capital Expenditures | -197.38M | -3.75M |
| Free Cash Flow | 19.92M | -4.78M |
| FCF Margin | 0.9% | -2.1% |
| Debt Repayment | -580.93M | -32,000 |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | ENOV | AXGN |
|---|---|---|
| Shares Short | 8.15M | 3.50M |
| Short Ratio | 8.66 | 4.04 |
| Short % of Float | 16.89% | 6.92% |
| Shares Outstanding | 57.19M | 47.20M |
| Float Shares | 56.33M | 50.75M |
| % Held by Insiders | 1.48% | 2.12% |
| % Held by Institutions | 117.25% | 88.11% |
| % Held by Public | -18.73% | 9.77% |
Dividend Analysis & Yield Comparison: Enovis Corporation vs Axogen Inc.
| Metric | ENOV | AXGN |
|---|---|---|
| Last 12-Month Dividend | $0.00 | $0.00 |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | $0.00 | $0.00 |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | $0.00 | $0.00 |
| Ex-Dividend Date | N/A | N/A |